Skip to Main Content

Paper Details

The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study.
Cancer
2
2023
CTLA-4, Immune-related adverse events, PD-1, advanced melanoma, anti-PD-1, anti-programmed death 1, cytotoxic T-lymphocyte, irAEs, melanoma, patients, steroids
Author NameAffiliation
Subha MadhavanInnovation Center for Biomedical Informatics, Georgetown University
Subha MadhavanInnovation Center for Biomedical Informatics, Georgetown University
Jaeil AhnGeorgetown University Medical Center
  • 1 - 3

Datasets

Release 1.2